Regression and pseudoprogression of pediatric optic pathway glioma in patients treated with proton beam therapy

2021 ◽  
Author(s):  
Sang Hee Youn ◽  
Haksoo Kim ◽  
Sang Hyeon Lee ◽  
Joo‐Young Kim
Keyword(s):  
Proton Beam ◽  
Proton Beam Therapy ◽  
Optic Pathway Glioma ◽  
Optic Pathway

Clinical Outcomes following Proton Beam Therapy for Sporadic Optic Pathway Glioma

2020 ◽  
Vol 108 (3) ◽  
pp. e239
Author(s):  
A.N. Hanania ◽  
M. Chintagumpala ◽  
E.B. Ludmir ◽  
V.S. Shah ◽  
S.L. McGovern ◽  
...  
Keyword(s):  
Clinical Outcomes ◽  
Proton Beam ◽  
Proton Beam Therapy ◽  
Optic Pathway Glioma ◽  
Optic Pathway

The regression patterns of pediatric optic pathway glioma after Proton Beam Therapy

2019 ◽  
Vol 105 (4) ◽  
pp. 912
Author(s):  
H. Kim ◽  
T. Kim ◽  
J. Jung ◽  
H. Kim ◽  
J. Kim
Keyword(s):  
Proton Beam ◽  
Proton Beam Therapy ◽  
Optic Pathway Glioma ◽  
Optic Pathway

Complications after Proton Beam Therapy to Skull Base Tumors: Case Series

2019 ◽  
Author(s):  
Gustavo Rangel ◽  
Mostafa Shahein ◽  
Thiago Felicio ◽  
Guilhermo Malave ◽  
Nyall London ◽  
...  
Keyword(s):  
Skull Base ◽  
Proton Beam ◽  
Case Series ◽  
Proton Beam Therapy ◽  
Skull Base Tumors

Proton Beam Therapy for Unresectable Adenoid Cystic Carcinoma of the Skull Base

Skull Base ◽  
2008 ◽  
Vol 18 (S 01) ◽  
Author(s):  
Annie Chan ◽  
Paul Busse ◽  
Urmila Kamat ◽  
Derrick Lin ◽  
Norbert Liebsch
Keyword(s):  
Adenoid Cystic Carcinoma ◽  
Skull Base ◽  
Proton Beam ◽  
Proton Beam Therapy ◽  
Adenoid Cystic

Proton Beam Therapy: The future of radiotherapy?

2018 ◽  
Author(s):  
Yen Ching Chang
Keyword(s):  
Proton Beam ◽  
Proton Beam Therapy ◽  
The Future

scholarly journals Feasibility of Proton Beam Therapy as a Rescue Therapy in Heavily Pre-Treated Retinoblastoma Eyes

Cancers ◽  
2021 ◽  
Vol 13 (8) ◽  
pp. 1862
Author(s):  
Eva Biewald ◽  
Tobias Kiefer ◽  
Dirk Geismar ◽  
Sabrina Schlüter ◽  
Anke Manthey ◽  
...  
Keyword(s):  
Proton Beam ◽  
Rescue Therapy ◽  
Therapeutic Option ◽  
Proton Beam Therapy ◽  
External Beam Radiation ◽  
Time Interval ◽  
Beam Radiation ◽  
Primary Tumors ◽  
Increased Risk

Despite the increased risk of subsequent primary tumors (SPTs) external beam radiation (EBRT) may be the only therapeutic option to preserve a retinoblastoma eye. Due to their physical properties, proton beam therapy (PBT) offers the possibility to use the effectiveness of EBRT in tumor treatment and to decisively reduce the treatment-related morbidity. We report our experiences of PBT as rescue therapy in a retrospectively studied cohort of 15 advanced retinoblastoma eyes as final option for eye-preserving therapy. The average age at the initiation of PBT was 35 (14–97) months, mean follow-up was 22 (2–46) months. Prior to PBT, all eyes were treated with systemic chemotherapy and a mean number of 7.1 additional treatments. Indication for PBT was non-feasibility of intra-arterial chemotherapy (IAC) in 10 eyes, tumor recurrence after IAC in another 3 eyes and diffuse infiltrating retinoblastoma in 2 eyes. Six eyes (40%) were enucleated after a mean time interval of 4.8 (1–8) months. Cataract formation was the most common complication affecting 44.4% of the preserved eyes, yet 77.8% achieved a visual acuity of >20/200. Two of the 15 children treated developed metastatic disease during follow-up, resulting in a 13.3% metastasis rate. PBT is a useful treatment modality as a rescue therapy in retinoblastoma eyes with an eye-preserving rate of 60%. As patients are at lifetime risk of SPTs consistent monitoring is mandatory.

Tumor and Dosimetric Predictors of Long-Term Visual Outcomes After Proton Beam Therapy of Uveal Melanoma

2014 ◽  
Vol 90 (1) ◽  
pp. S305 ◽  
Author(s):  
A.L. Polishchuk ◽  
D.H. Char ◽  
V. Weinberg ◽  
I.K. Daftari ◽  
T.B. Cole ◽  
...  
Keyword(s):  
Proton Beam ◽  
Uveal Melanoma ◽  
Proton Beam Therapy ◽  
Visual Outcomes

Postoperative hydrocephalus is a high-risk lethal factor for patients with low-grade optic pathway glioma

2021 ◽  
pp. 1-7
Author(s):  
Song Han ◽  
Zuocheng Yang ◽  
Liguo Wang ◽  
Yakun Yang ◽  
Xueling Qi ◽  
...  
Keyword(s):  
High Risk ◽  
Lethal Factor ◽  
Optic Pathway Glioma ◽  
Low Grade ◽  
Optic Pathway ◽  
Postoperative Hydrocephalus

scholarly journals Long‐term outcomes of high‐dose (74 GyE ) proton beam therapy with concurrent chemotherapy for stage III nonsmall‐cell lung cancer

2021 ◽  
Author(s):  
Kayoko Ohnishi ◽  
Hitoshi Ishikawa ◽  
Kensuke Nakazawa ◽  
Toshihiro Shiozawa ◽  
Yutaro Mori ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Proton Beam ◽  
Cell Lung Cancer ◽  
Nonsmall Cell Lung Cancer ◽  
Proton Beam Therapy ◽  
Concurrent Chemotherapy ◽  
Stage Iii ◽  
High Dose ◽  
Long Term Outcomes
Sign in / Sign up

Export Citation Format

Share Document